Essity AB consensus stays cautious, shares in focus among European staples
24.06.2026 - 12:18:39 | ad-hoc-news.de
By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-24, 10:16.
Essity AB (SE0009922164) sits firmly on investors' radar this week as analysts maintain a cautious consensus on the hygiene and health company, which trades on Nasdaq Stockholm alongside European staples peers such as EssilorLuxottica and Unilever. The focus is on how current earnings expectations and valuation stack up against the broader consumer goods sector, where price discipline and cost inflation remain key themes according to recent market commentary from major houses like UBS and JPMorgan. UBS sector overview on European consumer staples
What analysts say on Essity
Essity AB is covered by a compact but established group of European equity research houses, including Nordea, SEB and Jefferies, which broadly rate the stock between Hold and Buy with a cautious bias on upside. MarketScreener’s latest consensus snapshot for Essity shows most analysts clustered around a moderate upside scenario, with the average target price implying a mid-single-digit percentage potential compared with recent trading levels. MarketScreener consensus data for Essity
Jefferies, which also actively covers peer EssilorLuxottica on Euronext Paris, recently reiterated a constructive stance on the European personal care and hygiene space but highlighted valuation selectivity as crucial in the current rate environment. Jefferies update on EssilorLuxottica While the note focused on eyewear, it underlined a broader preference for companies with robust pricing power and scale - criteria that many investors also apply when assessing Essity’s tissue and hygiene portfolio.
Tuesday focus on consensus and peers
On the weekly calendar, Tuesday is often used by investors to recalibrate positioning around updated analyst models and sector comparisons, particularly in defensive pockets like consumer staples and healthcare. For Essity, this means its investment case is frequently examined in relation to North American staples benchmarks such as Procter & Gamble and Kimberly-Clark, where tissue and hygiene remain core profit drivers and pricing trends are closely watched in earnings seasons. Reuters analysis on consumer staples pricing
According to sector screens used by institutional investors, Essity typically trades at a valuation discount to premium household names like Procter & Gamble, reflecting its more Europe-focused footprint and different product mix, but the gap can narrow when the market seeks yield and earnings resilience. Consensus models currently factor in mid-single-digit organic sales growth for large staples, with margin resilience dependent on continued cost discipline and selective price increases after the sharp input cost inflation of the past two years. Bloomberg newsletter on staples margins
All news and analysis on the Essity AB shares
Current reports, consensus changes and background on Essity AB are collected in the dedicated topic section and on the company’s investor relations pages.
How Essity makes its money
Essity generates revenue primarily from hygiene and health products, with well-known brands in tissue, personal care and professional hygiene used in households, hospitals and workplaces worldwide. A representative product is the Tork professional hygiene range, which includes paper hand towels, soap and dispensers widely installed in offices, airports and public buildings across Europe and North America.
Where the shares trade today
The Essity AB shares (SE0009922164) trade on Nasdaq Stockholm; recent price data on June 24, 2026, 09:55 local time show the stock changing hands at 270.50 Swedish kronor.
Key data on the Essity AB shares
- Company: Essity AB (publ)
- ISIN: SE0009922164
- WKN: A2DJER
- Ticker: ESSITY B
- Trading venue: Nasdaq Stockholm
- Price (as of 2026-06-24, 09:55): 270.50 SEK
- Market cap: 186.0 billion SEK (as of 2026-06-24)
- Sector / industry: Consumer Staples / Personal Products & Hygiene
- Index membership: OMX Stockholm 30
- Next earnings date: 2026-07-18
Disclaimer: This article is for informational purposes only and does not constitute investment advice, investment recommendation or an offer or solicitation to buy or sell any financial instrument. Readers should conduct their own research and, where appropriate, seek professional advice before making investment decisions.
